BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 25816052)

  • 1. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
    Chen Y; Wang X; Chen G; Dong C; Zhang D
    PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
    Zhang DP; Li XW; Lang JH
    Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    Zhang Z; Luo G; Tang H; Cheng C; Wang P
    PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
    Soleyman-Jahi S; Nedjat S; Abdirad A; Hoorshad N; Heidari R; Zendehdel K
    PLoS One; 2014; 10(4):e0122316. PubMed ID: 25919283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
    Jiang H; Li H
    BMC Cancer; 2021 Feb; 21(1):149. PubMed ID: 33568081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
    Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of tumor-derived and stromal-derived matrix metalloproteinase 2 predicted prognosis of ovarian cancer.
    Fu Z; Xu S; Xu Y; Ma J; Li J; Xu P
    Int J Gynecol Cancer; 2015 Mar; 25(3):356-62. PubMed ID: 25695542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
    Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
    Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
    Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW
    Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of MMP-2 and Its Specific Inhibitor TIMP-2 Expression on the WHO Grade and Prognosis of Gliomas in Chinese Population: a Meta-Analysis.
    Yi GZ; Feng WY; Zhou Q; Liu YW; Qi ST
    Mol Neurobiol; 2017 Jan; 54(1):22-30. PubMed ID: 26729052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis.
    Shen W; Xi H; Wei B; Chen L
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):1003-9. PubMed ID: 24610446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
    Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
    Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
    Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
    Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.